Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The American Journal of Physiology|January 1, 1997
Measurement of hepatic Ra UDP-glucose in vivo in rats: relation to glycogen deposition and labeling patternsM K Hellerstein, A Letscher, J M Schwarz, et al.
Analytical Biochemistry|November 10, 2001
Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferationR A Neese, S Q Siler, D Cesar, et al.
Diabetologia|December 3, 2011
Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled studyC Beysen, E J Murphy, K Deines, et al.
The Journal of Biological Chemistry|March 14, 2000
A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretionG K Leung, M M Véniant, S K Kim, et al.
Biochimica Et Biophysica Acta|February 10, 2000
The contribution of newly synthesized cholesterol to bile salt synthesis in rats quantified by mass isotopomer distribution analysisR H Bandsma, F Kuipers, R J Vonk, et al.
The American Journal of Clinical Nutrition|July 17, 1998
De novo lipogenesis predicts short-term body-composition response by bioelectrical impedance analysis to oral nutritional supplements in HIV-associated wastingR Hoh, A Pelfini, R A Neese, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2002
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNAR A Neese, L M Misell, S Turner, et al.
The Journal of Clinical Investigation|December 20, 2000
Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100M M Véniant, M A Sullivan, S K Kim, et al.
The Journal of Experimental Medicine|November 7, 2001
Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapyH Mohri, A S Perelson, K Tung, et al.
The New England Journal of Medicine|February 15, 2001
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremiaS G Deeks, T Wrin, T Liegler, et al.
Pageof 9